In-vitro Antimicrobial Properties of Methanol extracts of three Medicinal Plants from Kilifi District - Kenya by Korir, R et al.
 
African Journal of Health Sciences, Volume 20, Number 1-2 January-March 2012 
 
4  
In-vitro Antimicrobial Properties of Methanol extracts of three Medicinal Plants from 
Kilifi District - Kenya 
 
Korir R1 Kimani C1 Gathirwa J1. Wambura M2 and Bii C1  
 
1Kenya Medical Research Institute – P.O box 54840 00200 Nairobi - Kenya  
2Jomo Kenyatta University of Agriculture and Technology – P.O box 62000 Thika- Kenya 
 




Multidrug resistant microbes are a health management challenge in immunocopromised individuals. The study 
aimed to evaluate antimicrobial potential and toxicity of the methanol extracts of Hosludia opposita, Rhus natalensis 
and Combretum illairii. The plants were collected from Kilifi District and authenticated at East African Herbarium. 
Samples collected were extracted in methanol. Quantitative bioassay was done using disc diffusion method; 
minimum inhibition concentration was done using broth dilution methods. The isolates used for bioactivity testing 
were Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Candida albicans and Trichophyton 
mentarophyte. Phytochemical screening was done using thin layer chromatograpy and cell toxicity was done using 
human embryonic lung cells. The H. opposita and C. illairii had terpenoids, flavonoids and anthaquinones. All the 
extracts were safe to the mammalian cells. Combretum illairii plant extracts had good activity against S. aureus and 
P. aeruginosa with inhibition zones diameters of 15.60 mm and 17.00 mm respectively. Rhus natalensis had an MIC 
of 6.25mg/ against both S. aureus and P. aeruginosa. The plant extracts were active against both bacteria and fungi. 
The result indicates that’s the plants extracts have potential for managing infections caused by the tested microbes. 








Opportunistic infections are a major challenge to people 
with HIV as susceptibility is increased due to weakened 
immune defenses. According to W.H.O clinical HIV- 
staging, some of the opportunistic infections 
characterizing clinical stage 2-4 are caused by bacterial 
and fungal infections. These include oral and 
Vulvovaginal candidiasis, cryptococcosis, and non-
typhoid Salmonella septicemia among others [17]. 
Emergence of microbes that are resistant to cheap first-
choice or “first-line” drugs is threatening the gains made 
by the discovery of antimicrobial agents during the 20th 
Century. Antibacterial and antifungal drug resistance is 
becoming a major problem in immunocompromised 
patients. People infected with HIV in whom drug 
resistance of the agent causing oropharyngeal candidiasis 
is a major problem.     
 
Until recently, available treatment for serious fungal 
infections comprised of amphotericin B and azoles, 
which have limitations [11]. Renal toxicity is a major 
concern with amphotericin B, while drug-drug 
interactions, hepatotoxicity, and skin rashes are the 
primary concerns with azoles [15]. Mainstream medicine 
is increasingly receptive to the use of antimicrobials and 
other drugs derived from plants. Traditional medicine has 
been an important source of products for the developing 
countries in treating common infections. For example, in 
Kenya about 400 plant species have been recorded as 
being used in traditional remedies [8, 11]. Traditional 
medicine is accepted by a majority of people because it is 
affordable and easy to access. While the benefits are 
appreciated, most of the traditional medicine used lack 
documented evidence of therapeutic efficacy, safety and 
quality. Numerous plants have been reported to possess 
antifungal activity. Here in Kenya, the petroleum ether 
fraction of` the aerial parts of Ajuga remota have been 
reported to have antifungal activity [7]. The ethanolic 
extract of the bark of Bersama lucens and 
Harperpyhullum caffrum have been reported to have 
activity against Candida albicans [8]. 
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Cassia species have been found to have good 
antimicrobial activity. The leaves and barks of Cassia 
alata have been reported to have antimicrobial activity in 
vitro, as potent as standard antimicrobial drugs against 
certain microorganisms. The water extracts of the bark 
had inhibition zones of 14.5 ± 0.3mm at a concentration 
of 30 µg/µl, while the inhibition zone of Triconazole was 
17.1± 1.9 mm at the same concentration, against C. 
albicans [15]. Methanol extracts of C. fistula had a 100% 
inhibition against C. albicans [1]. Methanol extracts of 
Aframomum melegueta seeds, Piper guineense seeds, 
Xylopia aethiopica fruits, and Zingiber afficinale 
rhizomes were found to be active against, Candida 
albicans and Aspergillus niger [9]. Fractions of 
Zygophyllum fabago showed very strong antifungal 
activity, achieving 95% growth inhibition while 
Vincetoxicum stocksii exhibited 85% growth inhibition 
against human pathogen C. albicans, as compared to its 
control, miconazole which showed a 100% growth 
inhibition at the same concentration [13]. Ground fresh 
leaves of H. opposita are soaked in water and the extract 
douched to treat vaginitis and drunk for treatment of 
hypertension. The roots are boiled and taken orally to 
cure children fever and convulsions [10]. Leaves are used 
for skin diseases and herpes zoster while the whole plant 
is used for liver cancer [2].  The plant is also used for the 
management of gonnorrhoea, blenorrhoea cystitis, liver 
disease, chest pain, cough, fever, hookworm, stomach 
disorders, wounds and mental disturbances [16]. The 
roots are used to treat malaria, epilepsy, convulsions and 
measles like swellings on the skin [6]. Antimalarial 
activity of R. natalensis collected in Meru district 
(Kenya) has been confirmed by Muthaura [14]. The plant 
was found to be safe both in vitro and in animal model 
[14]. Many plant species in the tropics still remain 
unexplored for their potential as medicinal agents, yet 
several reports indicates their use in traditional medicine 
[8, 4]. Due to HIV/AIDS pandemic and emerging 
resistance, toxicity and high cost of conventional drugs 
and their implication on mortality and morbidity we 
explored the potential use of H. opposita, R. natalensis 
and C. illairii as antimicrobial agents. To evaluate 
antimicrobial potential and toxicity of the methanol 
extracts of H. opposita, R. natalensis and C. illairii we 
collected, authenticated and extracted the three selected 
medicinal plants from Kilifi district (Kenya). 
Phytochemical screening, antimicrobial activity and 
toxicity of the methanolic extracts was done so as to 
determine their potential as antimicrobial agents. 
 
Materials and Methods  
Study Site 
The study was carried out at the Center for Traditional 
Medicine and Drug Research (CTMDR) and Center for 
Microbiology Research (CMR), Kenya Medical Research 
Institute (KEMRI). Extraction and in vitro toxicity was 
carried out at CTMDR while the bioassay was carried out 
at CMR. 
Collection and Preparation of Plant Samples  
The plants were collected from Kilifi District and 
authenticated at the East African Herbarium, Nairobi. 
Voucher specimen was deposited at the herbarium for 
future reference number KIF 019 H. opposita, KIF 025 
R. natalensis and KIF 039 C. illairii. Samples of roots 
stem and leaves were dried under shade, ground, 
catalogued and stored. Ground material (50-100 g) were 
extracted in methanol and concentrated by use of a rotary 
evaporator. Percentage yield of the dry materials was 
determined and the material preserved for use in 
biological assays. The extracts obtained were stored in 
airtight containers at room temperature for the bioassays. 
 
Antibacterial Bioassay 
The disc-diffusion assay was used to determine the 
growth inhibition caused by the extracts against the 
pathological bacterial strains Pseudomonas aeruginosa 
(ATCC 2785), Escherichia coli (ATCC 25922) and 
Staphylococcus aureus (ATCC 25923). The bacterial 
strains were obtained from the Center for Microbiology 
Research, KEMRI and standard isolates were used. The 
bacteria were maintained at 4 0C on nutrient agar (NA) 
plates. Base plates were prepared by pouring 20ml 
Mueller-Hinton (MH) agar into sterile Petri dishes and 
allowed to set. Molten MH agar held at 48 0C were 
inoculated with a broth culture of the test organism and 
poured over the base plates forming a homogenous top 
layer. Filter paper discs (Whatman No. 3, 6mm diameter) 
were sterilized by autoclaving. Ten µl of each extract 
(100mg/ml) were applied per filter paper disc so that 
each disc contained 100 mg/ml of extract. The discs were 
air dried and placed onto the seeded top layer of the MH 
agar plates. Each extract were tested in tripricate, at a 
concentration of 100mg/ml, with gentamicin (30 µg/ml) 
disc as reference or positive control. Air-dried 
Dimethylsulfoxide saturated discs were used as negative 
controls. The plates were evaluated after incubation at 37 
0C for 24 hr after which the zones of inhibition were 
measured. The size of the inhibition zone in (mm) 
produced by the plant extract and the inhibition zone 
around the gentamicin reference (mm) were used to 
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Minimum Inhibition Concentration 
Broth micro dilution method was used to determine 
minimum inhibitory concentration for the active crude 
extracts against the test microorganisms. The procedures 
were done as recommended by the National Committee 
for Clinical Laboratory Standards now Clinical 
Laboratory Standard Institute [18].  The tests were 
performed in 96 well-micro-titer plates. Plants extracts 
dissolved in respective solvents were transferred into 
micro-titer plates to make serial dilutions ranging 
from101, 102, 103……..1010.  The final volume in each 
well was 100 l. The wells were inoculated with 5l of 
microbial suspension. The yeast and bacteria were 
incubated at 370C for 24 hours while molds were 
incubated at 250C for 3-7 days in ambient air. The MIC 
was recorded as the lowest extract concentration 
demonstrating no visible growth as compared to the 
control broth turbidity [7, 12]. Wells that were not 
inoculated were set to act as control. All the experiments 




Antifungal activity was performed on Candida albicans 
(ATCC 90028) and Trichophyton mentagrophyte 
(clinical isolate). In vitro activity was performed as 
described for bacterial assays except that Sabourands 
dextrose agar was used for antifungal bioactivity testing 
and incubation was done at 30 0C for 24 hr for yeasts and 
72 hr for the filamentous fungi. All the bioassays were 
done in triplicate and results given as average results for 
three experiments.    
 
In-vitro Cytotoxicity Assay 
Human embryonic lung fibroblast (HELF) cells were 
used for the cytotoxicity assay. Cells were maintained in 
Minimum Essential Medium (MEM) containing 10 % 
fetal bovine serum (FBS).  2 x 105 cell suspensions were 
seeded on 96- well microtiter plates and incubated at 37 
0C / 5 % CO2 for 12 hours and different concentration of 
the drugs were added serially. Cells without drugs served 
as negative controls while wells with no cells or drug 
served as blanks. The plates were incubated for 48 hours 
at 37 0C, 5% CO2, followed by addition of MTT reagents 
to each well. Plates were incubated for another 4 hours. 
Media was removed from the wells and 100 µl of 
Dimethyl sulfoxide (DMSO) added. The plates were read 
on a scanning multi-well spectrophotometer at 562 nm 
and 620 nm as reference. Etoposide was used as a 
positive control/reference. The CC50 was determined 
using a dose-response curve  
  
Phytochemical Evaluation 
Phytochemical screening was done on the active extracts 
to determine the possible chemical principles present. 
Based on the initial bioassays the plant extracts 
exhibiting biological activity were screened for groups of 
chemical constituents. Thin layers chromatography plates 
were developed with Chloroforms: Methanol (98:2) with 
five drops of glacial acetic acid before spraying with 
TLC visualization reagents giving specific reactions.  
 
Data Analysis   
The results were presented in table forms. Test was done 
in triplicates and average results were computed using 
Excel computer package. The cytotoxic concentration 
causing 50% cell lysis and death (CC50) were determined 
for the extracts and analyzed using excel computer 




Phytochemical Compounds Present  
According to the results of the phytochemical screening 
study, all tested plant extracts were found to show a 
positive test for the presence of phenols. All the plants 
screened were negative for alkaloids. The H. opposita 
and C. illairii were positive for terpenoids, flavonoids 
and anthaquinones while R. natalensis was negative for 
the three compounds.  The results are as shown in table 1.  
 
Table 1: Phytochemical Profile of the Plants extracts 
Plants compounds  Plant species Solvents  
Terpenoids  Alkaloids Flavonoids Phenolics Anthraquinones  
H. opposita MeOH + - + + + 
R. natalensis MeOH - - - + - 
C. illairii MeOH + - + + + 
*Key: + Present, -Absent, MeOH Methanol extracts  
 
Bioactivity Testing 
Antibacterial Results  
The C. illairii plant extracts had good activity against S. 
aureus and P. aeruginosa with inhibition zones diameters 
of 15.60 and 17.00 mm respectively. The R. natalensis 
extracts had moderate activities with inhibition zone 
diameters of 11.6 mm while H. opposita had the least 
activities judged by the inhibition zones diameters of 
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6.60 and 7.60 mm against S. aureus and P. aeruginosa 
respectively. All the plants tested had no activities 
against E. coli.  The activity of the test plants expressed 
in inhibition zones diameters average for the triplicate 
tests are tabulated as shown in table 2.  
 
Table 2: Antimicrobial Activities of the three Plants Extracts against Bacterial Isolates   
Plant 
species  
Organisms  Inhibition zone diameters in 
mm 
Average in 









7 7 6 6.6 25.3 6 
Pseudomonas 
aeruginosa 
8 7 8 7.6 18 6 
H. opposita 
(Aerial parts) 
Escherichia coli 6 6 6 6 18 6 
Staphylococcus 
aureus 
11 12 12 11.6 25.3 6 
Pseudomonas 
aeruginosa 
12 11 12 11.6 18 6 
R. natalensis 
(Roots) 
Escherichia coli 6 6 6 6 18 6 
Staphylococcus 
aureus 
16 15 16 15.6 25.3 6 
Pseudomonas 
aeruginosa 
18 17 16 17 18 6 
C. illairii 
(Leaves ) 
Escherichia coli 6 6 6 6 18 6 
*Key: Positive Controls –X (gentamicin): Negative control – DMSO (Dimethlysulfoxide) 
Antifungal Results 
All the plant extracts tested against fungal isolates were 
least active judged by the presence of the inhibition zones 
diameters. The average zones were 6.00 and 7.30 mm. 
the results are as shown in table 3. 
 
Table 3: Antimicrobial Activities of the Plants Extracts against Fungal Isolates   
Plant 
species  
Organisms  Inhibition zone diameters in 
mm 












6 6 6 6 24 6 
Candida 
albicans  




6 6 6 6 24 6 
C. illairii Candida 7 7 8 7.3 25 6 
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(Leaves ) albicans  
 Trichophyton 
mentagrophyte 
6 6 6 6 24 6 
*Key: Positive control - Y (Fluconazole), Negative control – DMSO (Dimethlysulfoxide) 
 
Plates Showing Antibacterial Inhibition                                                   Plates Showing Antifungal Inhibition                                                                                          
Zones Exhibited by the Extracts                                                                Zones Exhibited by the Extracts                                                 
                                                                        
(a) Pseudomonas aeruginosa                                                                        (d) Candida albicans                                                          
                                                                                                                       
                                                               
(b) Staphylococcus aureus                                                                              (e) Trichophyton mentagrophyte                                                                        
 
The MIC Values of Active Plants Extracts against 
Bacteria Strains  
The MIC of the plant extracts which had inhibition 
diameters of 10 mm and above (significance activity) 
was determined. C. illairii leaves extracts had the least 
minimum inhibition concentration of 3.125 mg/ml 
against S. aureus and the highest MIC against P. 
aeruginosa of 12.50 mg/ml. The extracts of R. natalensis 
had MIC of 6.25 mg/ml against both S. aureus and P. 
aeruginosa. The results are as shown in table 4. 
 
Table 4: Minimum Inhibition Concentration 
 of Plants Extracts against Bacterial Isolate  
Plant 
species  


















Control  Gentamicin  0.5 
  
Cytotoxicity  
The concentration of herbal extract reducing cell viability 
by 50% (CC50) was determined for the three plant 
extracts. All the plant extracts were tested for toxicity 
using mammalian cells. The extracts were not cytotoxic 
at 100 mg/ml; H. opposita, R. natalensis and C. illairii 
extracts were safe to the mammalian cells with no 
apparent cytotoxic effect at 100 mg/ml. The CC50 in table 
5 at 500mg/ml and at 100mg/ml represents the number of 
cells remaining in each well after being subjected to 
cytotoxic effects of the extracts, since it is far from 50% 
all the extracts are not toxic as compared to the control 
which is below 50%. The results are as shown in table 5.    
 
Table 5: Cell Toxicity of Plant Extracts 
 Showing CC50 at 100mg/ml  
Plants 
species 




H. opposita Methanol  99.9 100 
R. 
natalensis 
Methanol  100 100 














Phytochemical Compounds Present  
The extracts of H. opposita, R. natalensis, C. illairii, 
were screened for the presence of different 
phytochemical compounds of therapeutic interest using 
chromatography visualization reagents  with the object of 
finding out the possible classes of compounds present in 
the respective plants. According to the results of the 
phytochemical screening study, all tested plant extracts 
were found to show a positive test for the presence of 
phenols. All the plants screened were negative for 
alkaloids. H. opposita and C. illairii were positive for 
terpenoids, flavonoids and anthaquinones while R. 
natalensis was negative for the three compounds. The 
presences of flavonoids, phenolics or terpenoids in plants 
have been reported to be responsible for antimicrobial 
activity in plants. Flavonoids and flavonoid-derived plant 
natural products have long been known to function as 
antimicrobial defense compounds. The different in vitro 
studies have also shown that they are effective 
antimicrobial substances against a wide spectrum of 
microorganisms. The antifungal and antibacterial activity 
of the plants studied was attributed to the presences of 
these secondary metabolites. In plants, their role is to 
protect plants against microorganisms and insects.  
 
Bioactivity Testing  
The C. illairii plant extracts had good activity against S. 
aureus and P. aeruginosa with inhibition zones diameters 
of 15.60 and 17.00 mm respectively.  This plant can be 
considered to be having good antimicrobial activities as 
compared to the other plants. The solvents used for 
extraction were used as negative control while 
fluconazoles and gentamicin were used as positive 
controls. The standards drugs (gentamycin and 
fluconazole) inhibition zone diametres was between 
16mm and 20mm which compared well with that of the 
C. illairii plant extracts. The extracts of R. natalensis had 
moderate activities with inhibition zone diameters of 
11.6mm while H. opposita had the least activities judged 
by the inhibition zones diameters of 6.60 and 7.60 mm 
against S. aureus and P. aeruginosa respectively. All the 
plants tested had no activities against E. coli.  The 
activity of the test plants expressed in inhibition zones 
diameters average for the triplicate tests are tabulated as 
shown previously. All the plant extracts tested against 
fungal isolates were least active judged by the presence 
of the inhibition zones diameters. The average zones 
were 6.00 and 7.30 mm. This results support the facts 
that most of this plants are used traditionally to treat and 
manage infections caused by bacterial pathogens as 
opposed to fungal infections.  
 
The MIC Values of Active Plants Extract against 
Bacteria Strains  
The preliminary screening assays for antimicrobial 
activity can largely be considered as qualitative assays 
and are used for identifying the presence or absence of 
bioactive constituents in the extracts. However, these 
methods of assay offer little information on these 
compounds. Minimum inhibitory concentration is a 
quantitative assay and provides more information on the 
potency of the compounds present in the extracts. Thus, 
the MIC values of crude extracts of the four medicinal 
plants were determined so as to demonstrate the potency 
of the extracts against the selected strains of bacteria. The 
MIC of the plant extracts which had inhibition diameters 
of 10 mm and above was determined. The C. illairii 
leaves extracts had the least minimum inhibition 
concentration of 3.125 mg/ml against S. aureus and the 
highest MIC against P. aeruginosa of 12.50 mg/ml. The 
least the MIC the better the plant extract against the 
isolate in question. The extracts of R. natalensis had an 
MIC of 6.25 mg/ml against both S. aureus and P. 
aeruginosa. The two plants extracts can be used to treat 
wound infection caused by S. aureus and P. aeruginosa 
since they have shown good activities.  
 
Cell Toxicity 
The concentration of herbal extract reducing cell viability 
by 50% (CC50) was determined for the three plant 
extracts. All the plant extracts were tested for toxicity 
using mammalian cells. The extracts were not cytotoxic 
at both concentration of 100 mg/ml and 500 mg/ml 
respectively; H. opposita, R. natalensis and C. illairii 
extracts were safe to the mammalian cells with no 
apparent cytotoxic effect at 100 mg/ml and 500 mg/ml. 
DMSO was used as a solvent in dissolving the organic 
solvent and hence used as a negative control while 
Epotoside drug was used as a positive control. The 
results are in agreement with other work done elsewhere 
[14] on antimalaria properties of the three plants, [3], 
found out that the stem bark extracts from this plant had 
neither cytotoxicity nor brine shrimp lethality. The three 
plant extracts tested had low toxicity as seen by their 
cytotoxic concentration above 50% against HELF cells, 
suggesting that they may be safe as antimicrobials.  
 
Conclusion  
The plant extracts in this study has high activity against 
bacteria strains as compared to fungal.  
Traditionally medicine plants decoction are taken in 
combination and at high dose, this may explain the low 
and moderate activity observed. In this study, all the 
plant extracts had no activity against E. coli thus treating 
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ailments caused by pathogenic strains of E. coli will not 
work. The results validate the ethnobotanical use of the 




Since the plant extracts are potent against bacterial 
isolates as compared to fungal then it is worth 
recommending the extracts be tested against a wide range 
of bacteria. All the plants are used traditionally for 
treating common colds which are caused by viral 
infection thus assays should be done on viral isolates. 
Analysis and isolation of the compounds present as well 
as determination of their bioactivity of the pure 
compounds should also be done. Such an effort could 
lead to identification of a new range of compounds for 
management of bacterial infections. Bioassay of 
combinations of plant extracts that exhibited moderate 
and low activity should be carried out to establish any 
synergism between them. Bioactivity on all parts of the 
plants for example, root, Stem bark and leaves combined 
so as to report conclusively that certain plant is inactive. 
Since some plants have good activities they should be 
formulated into different consumable forms as well as 
being incorporated into food as food supplements. The 
plants should be conserved in their natural environment 
so as to conserve our heritage.   
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